Skip to main content
. 2001 Apr;132(8):1650–1656. doi: 10.1038/sj.bjp.0703989

Figure 2.

Figure 2

Levels of dopaminergic nerve terminals, measured as density of specific [3H]-mazindol binding (nCi mm−2) within the striatum of wild-type and α4 nAChR subunit knockout mice treated with methamphetamine (5 mg kg−1; three injections i.p.; METH) and nicotine (1 mg kg−1; s.c.) plus methamphetamine (nicotine+METH). Each column represents the mean and s.e.mean of averaged triplicates or quadruplicates of the density of specific [3H]-mazindol binding measured in striata taken from 3 – 8 mice. Differences in dopaminergic nerve terminal survival were assessed by one-way ANOVA with a Dunnett's post-hoc test for multiple comparisons with a control, in wild-type and knockout mice, respectively, where P<0.05 was considered statistically significant. * (P<0.05).